Nervgen Pharma Corp.

NGEN Nasdaq SEC CIK 1751912

Follow Nervgen Pharma Corp. Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2025 CAD · IFRS

EPS, diluted -

Source: SEC XBRL filings · latest filing

No stories filed under Nervgen Pharma Corp. yet - coverage appears here as the news feed clusters it.

Profile · SEC EDGAR

Financials · SEC XBRL filings (IFRS)